Lantheus investor relations material

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. Lantheus has commercialized a portfolio of diagnostic tools used during the crucial first hours following myocardial infarction (MI), as well as products for ongoing use in the secondary prevention of cardiovascular disease in patients with established coronary artery disease. Lantheus commercializes its products through strategic relationships with hospital-based distributors and in-country agents.